ALPHA TEKNOVA INC (TKNO)
US02080L1026 - Common Stock
TKNO gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 58 industry peers in the Life Sciences Tools & Services industry. The financial health of TKNO is average, but there are quite some concerns on its profitability. TKNO is quite expensive at the moment. It does show a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year TKNO has reported negative net income.
TKNO had a negative operating cash flow in the past year.
TKNO had negative earnings in 4 of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: TKNO reported negative operating cash flow in multiple years.
1.2 Ratios
With a Return On Assets value of -29.71%, TKNO is not doing good in the industry: 72.41% of the companies in the same industry are doing better.
With a Return On Equity value of -43.42%, TKNO is not doing good in the industry: 65.52% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -29.71% | ||
| ROE | -43.42% | ||
| ROIC | N/A |
ROA(3y)-21.89%
ROA(5y)-13.43%
ROE(3y)-31.74%
ROE(5y)-19.4%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
Looking at the Gross Margin, with a value of 22.37%, TKNO is doing worse than 84.48% of the companies in the same industry.
In the last couple of years the Gross Margin of TKNO has declined.
TKNO does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 22.37% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-20.91%
GM growth 5YN/A
2. Health
2.1 Basic Checks
TKNO does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, TKNO has more shares outstanding
TKNO has a better debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 2.63 indicates that TKNO is not a great score, but indicates only limited risk for bankruptcy at the moment.
With a Altman-Z score value of 2.63, TKNO perfoms like the industry average, outperforming 51.72% of the companies in the same industry.
A Debt/Equity ratio of 0.16 indicates that TKNO is not too dependend on debt financing.
The Debt to Equity ratio of TKNO (0.16) is better than 62.07% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.16 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 2.63 |
ROIC/WACCN/A
WACC10.21%
2.3 Liquidity
A Current Ratio of 4.76 indicates that TKNO has no problem at all paying its short term obligations.
The Current ratio of TKNO (4.76) is better than 70.69% of its industry peers.
TKNO has a Quick Ratio of 3.28. This indicates that TKNO is financially healthy and has no problem in meeting its short term obligations.
TKNO has a better Quick ratio (3.28) than 62.07% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 4.76 | ||
| Quick Ratio | 3.28 |
3. Growth
3.1 Past
TKNO shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 50.00%, which is quite impressive.
The Revenue for TKNO has decreased by -10.93% in the past year. This is quite bad
TKNO shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.43% yearly.
EPS 1Y (TTM)50%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%27.78%
Revenue 1Y (TTM)-10.93%
Revenue growth 3Y5.43%
Revenue growth 5YN/A
Sales Q2Q%-16.6%
3.2 Future
TKNO is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 20.50% yearly.
Based on estimates for the next years, TKNO will show a quite strong growth in Revenue. The Revenue will grow by 15.69% on average per year.
EPS Next Y45.57%
EPS Next 2Y25.82%
EPS Next 3Y20.5%
EPS Next 5YN/A
Revenue Next Year-0.02%
Revenue Next 2Y7.17%
Revenue Next 3Y15.69%
Revenue Next 5YN/A
3.3 Evolution
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for TKNO. In the last year negative earnings were reported.
Also next year TKNO is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
A more expensive valuation may be justified as TKNO's earnings are expected to grow with 20.50% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y25.82%
EPS Next 3Y20.5%
5. Dividend
5.1 Amount
No dividends for TKNO!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
ALPHA TEKNOVA INC
NASDAQ:TKNO (9/18/2024, 9:30:37 AM)
4.95
+0.18 (+3.77%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap263.83M
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -29.71% | ||
| ROE | -43.42% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 22.37% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.3
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.16 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 4.76 | ||
| Quick Ratio | 3.28 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)50%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y45.57%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-10.93%
Revenue growth 3Y5.43%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y